Benevich Eric's Form 4/A amendment
AmendedNeurocrine Biosciences Inc (NBIX) · filed Jan 16, 2026
- Accession no.
- 0001643653-26-000005
- Filed
- Jan 16, 2026
- Trade date
- Nov 28, 2025
- Filing delay
- 49 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 2, 2025
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $905.9K. It was filed 49 days after the trade.
This amendment replaces 0001643653-25-000007 (filed Dec 2, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benevich EricCIK 0001643653 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | Common Stock | SSaleDisposed | −5,970 | $151.74 | −$905,887.8 | 44,893 | Direct | |
| Nov 28, 2025 | Common Stock | MOption exerciseAcquired | +12,830 | $35.99 | +$461,751.7 | 57,723 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | Common Stock | MOption exerciseDisposed | −12,830 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.